Pitt Street Research

Phylogica

Phylogica

Phylogica (ASX:PYC)

 

Phylogica is a peptide drug developer whose Phylomer platform allows it to identify cell-penetrating peptides that can hit hitherto ‘undruggable’ intracellular targets. The company has collaborated with the likes of AstraZeneca, Roche, Pfizer and J&J on drug discovery projects.


01/05/2017 In good company